Latest Capital Markets News

Orthocell has raised $30 million through an institutional placement to accelerate the US commercialisation of its flagship nerve repair product Remplir and expand its regenerative medicine portfolio.

Pinnacle Minerals Ltd is fast-tracking its U.S. growth by initiating a listing on the OTCQB Market and appointing key U.S. advisers to boost investor engagement and capital access.

Lake Resources N.L. has released a replacement prospectus for its bonus loyalty options offer, adjusting key terms and updating its capital structure ahead of the 17 October record date. The offer aims to reward shareholders while potentially raising capital for its Kachi lithium project.

Connexion Mobility reported a modest 1% revenue increase to $2.9 million in Q1 FY26, while net profit before tax declined 19% due to the absence of prior quarter government incentives. The company is advancing its SaaS platform footprint in US automotive retail and investing strategically in Covertrue Group.

TrivarX Limited has resumed trading on the ASX following the announcement of a significant acquisition and a fresh capital raising, signaling a pivotal moment for the biotech company.

TrivarX Limited has announced the acquisition of Stabl-Im, a novel stable isotope MRI technology for early brain tumor detection, backed by a $4.2 million capital raise including investment from biotech leader Dr Daniel Tillett.

QuickFee Limited reported a 9% revenue increase in Q1 FY26, driven by strong Australian Finance growth despite a US Finance dip. The company completed a US Pay Now business sale for US$26.35 million and announced a 7.5 cents per share capital return, alongside a CEO appointment.

European Lithium Limited signals a likely change to the timetable for its replacement options offer as 208 million options approach expiry in November. Investors await updated details amid potential capital structure implications.

Bod Science Limited reported a $576,000 net operating cash outflow for the September quarter, sustained by funding from Biortica Agrimed Limited under a Deed of Company Arrangement as it pursues a backdoor listing.

Skin Elements Limited has locked in $2.5 million through a two-tranche placement to accelerate the commercial rollout of its SE Formula biotechnology products, offering investors discounted shares and options.

Eclipse Metals announces plans for a NASDAQ dual listing to boost its rare earth elements strategy and tap into North American capital markets, while maintaining its ASX presence.

North Stawell Minerals (ASX – NSM) showcased promising high-grade gold intercepts at the Australian Gold Conference, reinforcing its position in Victoria’s prolific Stawell Mineralised Corridor. The company’s exploration pipeline, including the Darlington-Caledonia trend and Wildwood prospect, signals significant upside potential near existing milling infrastructure.